Q3 2015 Holdings
Filed 2015-11-16 | 87 holdings | $73.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ardelyx Inc(ARDX) | COM | 039697107 | $25.6M | 1,481,075 | 34.7% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $12.3M | 1,080,000 | 16.7% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $11.4M | 569,130 | 15.5% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $11.3M | 140,000 | 15.3% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $10.0M | 450,000 | 13.5% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $1.1M | 61,500 | 1.5% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $969.0K | 100,300 | 1.3% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $299.0K | 25,000 | 0.4% |
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $298.0K | 11,300 | 0.4% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $41.1K | 1,685,719 | 0.1% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $41.1K | 700,000 | 0.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $28.6K | 718,900 | 0.0% |
| Dyax Corp | COM | 26746E103 | $26.7K | 1,400,000 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $24.8K | 757,475 | 0.0% |
| Eagle Pharmaceuticals Inc(EGRX) | COM | 269796108 | $22.2K | 300,000 | 0.0% |
| Omeros Corp(OMER) | COM | 682143102 | $21.5K | 1,960,000 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $21.3K | 500,000 | 0.0% |
| Sorrento Therapeutics Inc(SRNE) | COM NEW | 83587F202 | $17.6K | 2,095,334 | 0.0% |
| Quotient LTD | SHS | G73268107 | $14.5K | 1,119,100 | 0.0% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $14.1K | 575,000 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $13.1K | 153,000 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $12.3K | 265,386 | 0.0% |
| Tesaro Inc | COM | 881569107 | $11.7K | 291,250 | 0.0% |
| Novavax Inc | COM | 670002104 | $11.3K | 1,600,000 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $10.5K | 109,500 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $10.2K | 240,000 | 0.0% |
| China Biologic Prods Inc | COM | 16938C106 | $10.0K | 111,500 | 0.0% |
| Recro Pharma Inc | COM | 75629F109 | $9.4K | 780,000 | 0.0% |
| Pfenex Inc | COM | 717071104 | $9.4K | 624,900 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $8.8K | 255,000 | 0.0% |
| Rockwell MED Inc | COM | 774374102 | $8.5K | 1,105,000 | 0.0% |
| Advaxis Inc | COM NEW | 007624208 | $8.2K | 800,000 | 0.0% |
| Forward Pharma A/S | SPONSORED ADR | 34986J105 | $7.9K | 335,068 | 0.0% |
| Lipocine Inc New | COM | 53630X104 | $7.9K | 666,666 | 0.0% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $7.4K | 250,000 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $7.2K | 1,559,000 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $6.0K | 1,145,043 | 0.0% |
| Regulus Therapeutics Inc | COM | 75915K101 | $5.9K | 896,522 | 0.0% |
| Curis Inc | COM | 231269101 | $5.3K | 2,632,000 | 0.0% |
| Zynerba Pharmaceuticals Inc | COM | 98986X109 | $5.1K | 356,600 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $5.0K | 200,000 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $4.7K | 150,000 | 0.0% |
| Aptose Biosciences Inc | COM NEW | 03835T200 | $4.7K | 1,081,867 | 0.0% |
| Intec Pharma LTD Jerusalem | SHS | M53644106 | $4.5K | 800,000 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $4.4K | 397,500 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $4.0K | 170,000 | 0.0% |
| Epirus Biopharmaceuticals Inc | COM | 29428P107 | $4.0K | 896,600 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $3.9K | 850,000 | 0.0% |
| Kite Pharma Inc | COM | 49803L109 | $3.8K | 68,800 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $3.5K | 156,741 | 0.0% |